EU Accepts Sanofi's Concessions to End Antitrust Probe Over Vaccine Marketing — Update
Sanofi SA SNYNF
News
EU Accepts Sanofi's Concessions to Settle Antitrust Probe Over Vaccine Marketing
Flu season is already here. Here's what to know about this year's flu shots.
Sanofi, Regeneron to Expand Alliance in Up to $8 Billion Deal — Update
Sanofi, Regeneron to Expand Alliance in Deal Valued at Up to $8 Billion
European Pharma Leaders Push for National Reforms to Boost Investment
Sanofi to Take Stake in Cheplapharm in Swap for Drug Portfolio, Manufacturing Sites
FDA Approves Seasonal Covid-19 Vaccines From Moderna, Pfizer, BioNTech, Novavax — Update
Sanofi Shares Slide After CEO Signals Challenges to Fill Drug Pipeline
Sanofi Raises Guidance as New CEO Looks to Revamp Drug Pipeline
Sanofi to Drop Eczema Drug Amid Review of Pipeline Under New CEO
Scribe Therapeutics to Sell 7.15 Million Shares at $13-$15 Each in IPO
EU Seeks Views on Sanofi's Concessions to End Competition Probe — Update
EU Seeks Views on Sanofi's Concessions to End Competition Probe
Sanofi Drug for Rare Neuromuscular Disease Hits Goals in Late-Stage Trial
Sanofi Probed by EU Over Flu Vaccine Marketing
Sanofi Multiple Sclerosis Drug Gets EU Approval — Update
Sanofi Multiple Sclerosis Drug Gets EU Approval
Sanofi Names New Pharma Research Head as CEO Moves to Speed Up Pipeline — Update
Sanofi Names New Pharma Research Head After Drug Setbacks
United States